A Multicenter Prospective Cohort Study Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction Failure - Trial NCT05875649
Access comprehensive clinical trial information for NCT05875649 through Pure Global AI's free database. This phase not specified trial is sponsored by Nanfang Hospital, Southern Medical University and is currently Not yet recruiting. The study focuses on AML. Target enrollment is 137 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Nanfang Hospital, Southern Medical University
Timeline & Enrollment
N/A
Jul 02, 2023
Dec 20, 2027
Primary Outcome
Study of CLAG Regimen in Acute Myeloid Leukemia Patients With First-induction failure
Summary
Most of patients with acute myeloid leukemia achieved complete remission (CR) after primary
 induction chemotherapy, there were 20-30% patients without CR after first-induction. It was
 uncertain how to treat these patients. It was investigated in our study that these patients
 were re-induced with CLAG Regimen. The CR ratio, overall survival (OS) and relapsed-free
 survival (RFS) was statistically analysed in these patients.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05875649
Non-Device Trial